| Application number | Title of the application | Filing Date | Status |
|---|
| 09/365654 | HERPESVIRAL VECTORS FOR GENE DELIVERY | Aug 1, 1999 | Abandoned |
Array
(
[id] => 6047755
[patent_doc_number] => 20020168694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-14
[patent_title] => 'METHOD FOR MAINTENANCE AND PROPAGATION OF GERMLINE STEM CELLS USING MEMBERS OF THE TFG-B FAMILY OF GROWTH FACTORS'
[patent_app_type] => new
[patent_app_number] => 09/358937
[patent_app_country] => US
[patent_app_date] => 1999-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13533
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0168/20020168694.pdf
[firstpage_image] =>[orig_patent_app_number] => 09358937
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/358937 | Method for maintenance and propagation of germline stem cells using members of the TFG- family of growth factors | Jul 22, 1999 | Issued |
Array
(
[id] => 1396776
[patent_doc_number] => 06537777
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Human porphobilinogen deaminase sequences'
[patent_app_type] => B1
[patent_app_number] => 09/358856
[patent_app_country] => US
[patent_app_date] => 1999-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 31169
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537777.pdf
[firstpage_image] =>[orig_patent_app_number] => 09358856
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/358856 | Human porphobilinogen deaminase sequences | Jul 21, 1999 | Issued |
| 09/358322 | EHRLICHIA CANIS GENES AND VACCINES | Jul 20, 1999 | Abandoned |
Array
(
[id] => 6746813
[patent_doc_number] => 20030023996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'HUMAN FAT-2 (HFAT2)'
[patent_app_type] => new
[patent_app_number] => 09/358635
[patent_app_country] => US
[patent_app_date] => 1999-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7248
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20030023996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09358635
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/358635 | HUMAN FAT-2 (HFAT2) | Jul 20, 1999 | Abandoned |
Array
(
[id] => 627229
[patent_doc_number] => 07135613
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-14
[patent_title] => 'Chimeric gene constructs for generation of fluorescent transgenic ornamental fish'
[patent_app_type] => utility
[patent_app_number] => 09/913898
[patent_app_country] => US
[patent_app_date] => 1999-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 25
[patent_no_of_words] => 11172
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135613.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913898
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913898 | Chimeric gene constructs for generation of fluorescent transgenic ornamental fish | Jul 15, 1999 | Issued |
Array
(
[id] => 1383098
[patent_doc_number] => 06555672
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Growth differentiation factor promoter and uses therefor'
[patent_app_type] => B1
[patent_app_number] => 09/354409
[patent_app_country] => US
[patent_app_date] => 1999-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 17
[patent_no_of_words] => 7095
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555672.pdf
[firstpage_image] =>[orig_patent_app_number] => 09354409
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/354409 | Growth differentiation factor promoter and uses therefor | Jul 14, 1999 | Issued |
Array
(
[id] => 6544928
[patent_doc_number] => 20020137699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'EXPRESSION SYSTEMS COMPRISING CHIMERIC PROMOTERS WITH BINDING SITES FOR RECOMBINANT TRANSCRIPTION FACTORS'
[patent_app_type] => new
[patent_app_number] => 09/352767
[patent_app_country] => US
[patent_app_date] => 1999-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15555
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137699.pdf
[firstpage_image] =>[orig_patent_app_number] => 09352767
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/352767 | EXPRESSION SYSTEMS COMPRISING CHIMERIC PROMOTERS WITH BINDING SITES FOR RECOMBINANT TRANSCRIPTION FACTORS | Jul 13, 1999 | Abandoned |
| 09/341350 | METHOD FOR TRANSFERRING NUCLEIC ACID INTO THE STRIPED MUSCLE AND COMBINATION THEREFOR | Jul 8, 1999 | Abandoned |
Array
(
[id] => 1037164
[patent_doc_number] => 06872389
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'Liver stem cell'
[patent_app_type] => utility
[patent_app_number] => 09/743544
[patent_app_country] => US
[patent_app_date] => 1999-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 4824
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872389.pdf
[firstpage_image] =>[orig_patent_app_number] => 09743544
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/743544 | Liver stem cell | Jul 7, 1999 | Issued |
Array
(
[id] => 1499208
[patent_doc_number] => 06485722
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'Method for selective engraftment of drug-resistant hematopoietic stem cells'
[patent_app_type] => B1
[patent_app_number] => 09/142126
[patent_app_country] => US
[patent_app_date] => 1999-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5936
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/485/06485722.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142126
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142126 | Method for selective engraftment of drug-resistant hematopoietic stem cells | Jul 5, 1999 | Issued |
Array
(
[id] => 769297
[patent_doc_number] => 07005423
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-28
[patent_title] => 'Characterization of gene function using double stranded RNA inhibition'
[patent_app_type] => utility
[patent_app_number] => 09/347311
[patent_app_country] => US
[patent_app_date] => 1999-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10472
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/005/07005423.pdf
[firstpage_image] =>[orig_patent_app_number] => 09347311
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/347311 | Characterization of gene function using double stranded RNA inhibition | Jul 1, 1999 | Issued |
Array
(
[id] => 5887914
[patent_doc_number] => 20020012656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES'
[patent_app_type] => new
[patent_app_number] => 09/147948
[patent_app_country] => US
[patent_app_date] => 1999-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3414
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20020012656.pdf
[firstpage_image] =>[orig_patent_app_number] => 09147948
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147948 | Adenoviral vectors for mutants of human interleukin 6 (hIL-6) with hIL-6 antagonist activity, pharmaceutical compositions therewith and their uses | Jun 29, 1999 | Issued |
Array
(
[id] => 1303556
[patent_doc_number] => 06620800
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-16
[patent_title] => 'Methods and compositions to assess oxidative brain injury'
[patent_app_type] => B1
[patent_app_number] => 09/342813
[patent_app_country] => US
[patent_app_date] => 1999-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10995
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/620/06620800.pdf
[firstpage_image] =>[orig_patent_app_number] => 09342813
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/342813 | Methods and compositions to assess oxidative brain injury | Jun 28, 1999 | Issued |
Array
(
[id] => 4296451
[patent_doc_number] => 06251383
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Method for ex-vivo expansion of hematopoietic cells'
[patent_app_type] => 1
[patent_app_number] => 9/339759
[patent_app_country] => US
[patent_app_date] => 1999-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3952
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251383.pdf
[firstpage_image] =>[orig_patent_app_number] => 339759
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/339759 | Method for ex-vivo expansion of hematopoietic cells | Jun 23, 1999 | Issued |
| 09/337079 | TREATMENT OF STAPHYLOCOCCUS INFECTIONS | Jun 20, 1999 | Abandoned |
Array
(
[id] => 1391556
[patent_doc_number] => 06548653
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-15
[patent_title] => 'Erythropoietin analog-human serum albumin fusion'
[patent_app_type] => B1
[patent_app_number] => 09/333213
[patent_app_country] => US
[patent_app_date] => 1999-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20759
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/548/06548653.pdf
[firstpage_image] =>[orig_patent_app_number] => 09333213
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/333213 | Erythropoietin analog-human serum albumin fusion | Jun 14, 1999 | Issued |
| 09/333229 | CAMELLO GENE FAMILY AND USES THEREOF | Jun 13, 1999 | Abandoned |
Array
(
[id] => 1043763
[patent_doc_number] => 06867196
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-15
[patent_title] => 'Process for delivering nucleic acids to cardiac tissue'
[patent_app_type] => utility
[patent_app_number] => 09/330909
[patent_app_country] => US
[patent_app_date] => 1999-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8510
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/867/06867196.pdf
[firstpage_image] =>[orig_patent_app_number] => 09330909
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/330909 | Process for delivering nucleic acids to cardiac tissue | Jun 10, 1999 | Issued |
Array
(
[id] => 6062867
[patent_doc_number] => 20020031494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-14
[patent_title] => 'NUCLEIC ACIDS FOR REDUCING CARBOHYDRATE EPITOPES'
[patent_app_type] => new
[patent_app_number] => 09/254077
[patent_app_country] => US
[patent_app_date] => 1999-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6628
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20020031494.pdf
[firstpage_image] =>[orig_patent_app_number] => 09254077
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/254077 | Nucleic acids for reducing carbohydrate epitopes | Jun 10, 1999 | Issued |